152 related articles for article (PubMed ID: 213603)
1. Cerebral astrocytomata--trends in radiotherapy and chemotherapy: a review.
Jones A
J R Soc Med; 1978 Sep; 71(9):669-74. PubMed ID: 213603
[No Abstract] [Full Text] [Related]
2. Radiation plus metronidazole for glioblastoma.
Urtasun RC; Band PR; Chapman JD; Feldstein ML
N Engl J Med; 1977 Mar; 296(13):757. PubMed ID: 190541
[No Abstract] [Full Text] [Related]
3. Current approaches in the treatment of malignant gliomas of the brain.
Nelson G
J Neurosurg Nurs; 1974 Dec; 6(2):109-16. PubMed ID: 4140902
[No Abstract] [Full Text] [Related]
4. Adjuvant therapy in the treatment of malignant glioma.
Kim RY; Langford KH; Roth RE
J Med Assoc State Ala; 1977 Oct; 47(4):39-41. PubMed ID: 200689
[No Abstract] [Full Text] [Related]
5. Adjuvant chemotherapy with nitrosourea compounds following surgery plus radiotherapy in glioblastoma multiforme.
Monfardini S; Brambilla C; Solero CL; Vaghi A; Valagussa P; Morello G; Bonadonna G
Recent Results Cancer Res; 1978; 68():393-8. PubMed ID: 223206
[No Abstract] [Full Text] [Related]
6. Combined modality therapy for intracranial tumors.
Bloom HJ
Cancer; 1975 Jan; 35(1):111-20. PubMed ID: 162849
[TBL] [Abstract][Full Text] [Related]
7. Management of some intracranial tumors in children and adults.
Bloom HJ
Prog Clin Biol Res; 1978; 25():55-84. PubMed ID: 216024
[No Abstract] [Full Text] [Related]
8. [Retrospective analysis of 24 recurrent glioblastoma after chemoradiation and treated with nitrosoureas or irinotecan and bevacizumab].
Vauleon E; Mesbah H; Gedouin D; Lecouillard I; Louvel G; Hamlat A; Riffaud L; Carsin B; Quillien V; Audrain O; Lesimple T
Bull Cancer; 2012 Feb; 99(2):121-6. PubMed ID: 22257744
[TBL] [Abstract][Full Text] [Related]
9. [Significance of the combined use of radiosensitizing agents on radiotherapy of malignant encephaloma].
Hoshino T
Rinsho Hoshasen; 1968 Nov; 13(11):885-91. PubMed ID: 4304555
[No Abstract] [Full Text] [Related]
10. Adjuvant chemotherapy with VM 26 and CCNU after operation and radiotherapy of high-grade supratentorial astrocytomas.
Seiler RW; Zimmermann A; Markwalder H
Surg Neurol; 1980 Jan; 13(1):65-8. PubMed ID: 6244679
[TBL] [Abstract][Full Text] [Related]
11. Intracranial tumors: response and resistance to therapeutic endeavors, 1970-1980.
Bloom HJ
Int J Radiat Oncol Biol Phys; 1982 Jul; 8(7):1083-113. PubMed ID: 6288633
[No Abstract] [Full Text] [Related]
12. Editorial: Hypoxic cell radiosensitizers.
Belli JA; Hellman S
N Engl J Med; 1976 Jun; 294(25):1399-400. PubMed ID: 177876
[No Abstract] [Full Text] [Related]
13. Radiotherapy and chemotherapy with or without carbogen and nicotinamide in inoperable biopsy-proven glioblastoma multiforme.
Simon JM; Noël G; Chiras J; Hoang-Xuan K; Delattre JY; Baillet F; Mazeron JJ
Radiother Oncol; 2003 Apr; 67(1):45-51. PubMed ID: 12758239
[TBL] [Abstract][Full Text] [Related]
14. [Combined treatment of glyal and metastatic tumors of the brain].
Fadeev BP; Zhabina RM
Vestn Khir Im I I Grek; 2005; 164(1):80-2. PubMed ID: 15957817
[TBL] [Abstract][Full Text] [Related]
15. Morphologic changes associated with combined BCNU and radiation therapy in glioblastoma multiforme.
Willson N; Duffy PE
Neurology; 1974 May; 24(5):465-71. PubMed ID: 4363818
[No Abstract] [Full Text] [Related]
16. Recent advances in the treatment of primary brain tumors. A seminar.
Arch Surg; 1975 Jun; 110(6):696-702. PubMed ID: 167675
[No Abstract] [Full Text] [Related]
17. Carboplatin and teniposide concurrent with radiotherapy in patients with glioblastoma multiforme: a phase II study.
Brandes AA; Rigon A; Zampieri P; Ermani M; Carollo C; Altavilla G; Turazzi S; Chierichetti F; Florentino MV
Cancer; 1998 Jan; 82(2):355-61. PubMed ID: 9445194
[TBL] [Abstract][Full Text] [Related]
18. Halogenated pyrimidines as radiosensitizers for high grade glioma: revisited.
Rodriguez R; Kinsella TJ
Int J Radiat Oncol Biol Phys; 1991 Aug; 21(3):859-62; discussion 865. PubMed ID: 1651310
[No Abstract] [Full Text] [Related]
19. Early necrosis following concurrent Temodar and radiotherapy in patients with glioblastoma.
Chamberlain MC; Glantz MJ; Chalmers L; Van Horn A; Sloan AE
J Neurooncol; 2007 Mar; 82(1):81-3. PubMed ID: 16944309
[TBL] [Abstract][Full Text] [Related]
20. The PI3K inhibitor GDC-0941 enhances radiosensitization and reduces chemoresistance to temozolomide in GBM cell lines.
Shi F; Guo H; Zhang R; Liu H; Wu L; Wu Q; Liu J; Liu T; Zhang Q
Neuroscience; 2017 Mar; 346():298-308. PubMed ID: 28147244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
